Yvan Vandenplas1, Johan Marchand, Lien Meyns. 1. Department of Pediatrics, UZ Brussel, Laarbeeklaan 101, 1090 Brussels, Belgium. yvan.vandenplas@uzbrussel.be.
Abstract
INTRODUCTION: The diagnosis and management of cow's milk allergy (CMA) is a topic of debate because there are no specific symptoms and reliable diagnostic tests. METHOD: Literature was searched using databases to find original papers and reviews on this topic. RESULTS: A "challenge test" is still recommended as the most specific and sensitive diagnostic test, although a positive challenge test does not proof the involvement of the immune system. Only in the rare case of anaphylaxis, the challenge tests is not recommended. The Cow's Milk Symptom Score (CoMiSS) is an awareness tool for health care professionals to better recognize symptoms caused by the ingestion of cow's milk, but still needs validation. Today, the recommended diagnostic approach consists of an elimination diet with an extensive cow's milk based hydrolysate, followed by a challenge test. Amino acid based formula is reserved for the severe cases. Rice hydrolysates are gaining popularity, because they have been shown to be effective, have a better acceptability, and to be cheaper than the extensive cow's milk based hydrolysates. Soy infant formula may offer an additional alternative option as reviews concluded that about 10-15% of infants allergic to cow's milk will also react to soy. Gastro-intestinal microbiota manipulation may be of additional benefit in the treatment of CMA. CONCLUSION: The development of rice hydrolysates challenge the use of Today, extensive cow's milk based extensive hydrolysates remain the first option for the majority of patients and amino acid formula for the most severe cases. Rice hydrolysates and soy infant formula are considered as second choice options.
INTRODUCTION: The diagnosis and management of cow's milk allergy (CMA) is a topic of debate because there are no specific symptoms and reliable diagnostic tests. METHOD: Literature was searched using databases to find original papers and reviews on this topic. RESULTS: A "challenge test" is still recommended as the most specific and sensitive diagnostic test, although a positive challenge test does not proof the involvement of the immune system. Only in the rare case of anaphylaxis, the challenge tests is not recommended. The Cow's Milk Symptom Score (CoMiSS) is an awareness tool for health care professionals to better recognize symptoms caused by the ingestion of cow's milk, but still needs validation. Today, the recommended diagnostic approach consists of an elimination diet with an extensive cow's milk based hydrolysate, followed by a challenge test. Amino acid based formula is reserved for the severe cases. Rice hydrolysates are gaining popularity, because they have been shown to be effective, have a better acceptability, and to be cheaper than the extensive cow's milk based hydrolysates. Soy infant formula may offer an additional alternative option as reviews concluded that about 10-15% of infants allergic to cow's milk will also react to soy. Gastro-intestinal microbiota manipulation may be of additional benefit in the treatment of CMA. CONCLUSION: The development of rice hydrolysates challenge the use of Today, extensive cow's milk based extensive hydrolysates remain the first option for the majority of patients and amino acid formula for the most severe cases. Rice hydrolysates and soy infant formula are considered as second choice options.
Authors: Adam T Fox; Harm Wopereis; Marleen T J Van Ampting; Manon M Oude Nijhuis; Assad M Butt; Diego G Peroni; Yvan Vandenplas; David C A Candy; Neil Shah; Christina E West; Johan Garssen; Lucien F Harthoorn; Jan Knol; Louise J Michaelis Journal: Clin Transl Allergy Date: 2019-01-15 Impact factor: 5.871
Authors: Joris H J van Sadelhoff; Astrid Hogenkamp; Selma P Wiertsema; Lucien F Harthoorn; Reinilde Loonstra; Anita Hartog; Johan Garssen Journal: Immun Inflamm Dis Date: 2020-02-07
Authors: Rita Nocerino; Carmen Di Scala; Serena Coppola; Veronica Giglio; Laura Carucci; Linda Cosenza; Luana Voto; Anna Maria Iannicelli; Anna Luzzetti; Roberto Berni Canani Journal: Ital J Pediatr Date: 2021-07-03 Impact factor: 2.638